Badesch David B, Champion Hunter C, Gomez Sanchez Miguel Angel, Hoeper Marius M, Loyd James E, Manes Alessandra, McGoon Michael, Naeije Robert, Olschewski Horst, Oudiz Ronald J, Torbicki Adam
Divisions of Pulmonary Sciences and Critical Care Medicine and Cardiology, University of Colorado Health Sciences Center, Denver, Colorado.
Division of Cardiology, Johns Hopkins University, Baltimore, Maryland.
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S55-S66. doi: 10.1016/j.jacc.2009.04.011.
The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment. The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence. There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy. The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated. As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important. A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium.
肺动脉高压的诊断与评估是一个快速发展的领域,在疾病定义、筛查与诊断技术以及分期和随访评估方面都在发生变化。肺动脉高压的定义已经简化,现在基于现有证据。在推进用于筛查患者疾病及随访其治疗反应的成像技术和生物标志物方面取得了重大进展。人们更加充分地认识到准确评估右心室功能在跟踪临床病程和治疗反应中的重要性。随着针对肺动脉高压的新疗法不断研发,筛查、及时诊断以及准确评估疾病严重程度变得愈发重要。明确肺动脉高压的定义,并制定使用传统和新工具进行诊断评估及随访的合理方法,对于从我们不断扩充的治疗手段中获得最大益处至关重要。